Skip to main content
Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
4.180
+0.060 (1.46%)
At close: Dec 5, 2025, 4:00 PM EST
4.400
+0.220 (5.26%)
After-hours: Dec 5, 2025, 7:56 PM EST

UPC Revenue

Universe Pharmaceuticals INC had revenue of $9.15M in the half year ending March 31, 2025, a decrease of -50.44%. This brings the company's revenue in the last twelve months to $19.29M, down -27.81% year-over-year. In the fiscal year ending September 30, 2024, Universe Pharmaceuticals INC had annual revenue of $23.02M, down -28.74%.

Revenue (ttm)
$19.29M
Revenue Growth
-27.81%
P/S Ratio
0.04
Revenue / Employee
$85,747
Employees
225
Market Cap
2.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202423.02M-9.28M-28.74%
Sep 30, 202332.31M-7.83M-19.52%
Sep 30, 202240.14M-7.84M-16.34%
Sep 30, 202147.98M17.28M56.27%
Sep 30, 202030.70M-2.53M-7.60%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

UPC News

More News